Skip to main content

Table 1 Background information on the study sites, professionals, and drug products

From: The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study

Variables

Category

Frequency

Percentage

Facility type (n = 26)

Tertiary/teaching hospital

2

7.7

General hospital

15

57.7

Primary hospital

9

34.6

Public supply agency (hubs)

2

-

Store manager (n = 26)

Pharmacistb

20

77

Druggistb

5

19.2

Nurse

1

3.8

Work experience of store manager (years)

(n = 26)

 ≤ 2

6

23.1

3–5

11

42.3

 > 5

9

34.6

Product categories (n = 28 drug formulations on EML)

CVD medicines

19

67.8

Antidiabetics

5

17.9

Paracetamol products

4

14.3

Antidiabetics (n = 5)

Insulin products

3

60

Oral hypoglycemic agents

2

40

CVD medicines (n = 19)

ACEIs/ARB

3

15.8

Beta- blockers

3

15.8

Diuretics

4

21.1

Statins

3

15.8

Digoxin products

2

10.5

Calcium channel products

2

10.5

Othersa

2

10.5

  1. ACEIs/ARB Angiotensin Converting Enzyme Inhibitors/ Angiotensin Receptor Blockers, CVD Cardiovascular disease
  2. a Methyldopa, Aspirin (81 mg); EML: Essential Medicine List
  3. bPharmacists have a bachelor's degree in pharmacy and have received five years of training. Druggists, on the other hand, are pharmacy technicians who have received two years of training and typically support pharmacist services in hospitals